Factor XII (12) Inhibitor Titer - Machaon Diagnostics
New test available: mHam 2.0 – Complement-Dependent Cell Killing Assay

Test Directory

Home Test Search Results Factor XII (12) Inhibitor Titer
Factor XII (12) Inhibitor Titer

Justification

Acquired factor deficiencies may occur due to the development of factor-specific inhibitory antibodies. These antibodies may also develop against factor replacement products in patients with a congenital deficiency. This test may be used to detect and quantitate inhibitory antibodies against Factor XII.

STAT: < 24 hours (7 days a week)

Bethesda, Clot-based

Draw Tube: Blue Top

Sample Type: Citrated Plasma

Specimen Requirements

Sample Type Volume Required Minimum Volume Stability
PREFERRED Citrated Plasma Two aliquots, 1mL each Two aliquots, 0.5mL each Frozen (-20C): 2 weeks
Frozen (-80C): 6 months
ALTERNATIVE - - - -
REJECTION CRITERIA Thawed in transit, refrozen or clotted sample
SPECIAL INSTRUCTIONS -

General Information

METHODOLOGY Bethesda, Clot-based
STAT TAT < 24 hours (7 days a week)
STAT TAT Performance > 90% of results released in 24 hours 7 days a week
ROUTINE TAT < 3 days (M-F)
ALTERNATIVE NAMES Hageman Factor inhibitor, F12 inhibitor, FXII inhibitor
DESCRIPTION Bethesda titer for the quantitative determination of a specific factor inhibitor against factor XII (12).
LIMITATIONS -
NORMAL RANGE < 0.4 BU
ASSOCIATED TESTING -
REFERENCES -
SAMPLE REPORT Upon request
NEW YORK STATE APPROVED No

Test Codes

ORDER CODE P3417
CPT CODE 85280, 85335
LOINC CODE 3232-6